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Abstract 
 
Head and neck cancer (HNC) is the sixth most common malignancy worldwide. Squamous cell carcinoma, the primary cause of 
HNC, evolves from normal epithelium through dysplasia before invading the connective tissue to form a carcinoma. Only 5% of 
suspicious lesions progress to cancer and diagnosis currently relies on histopathological evaluation, which is invasive and time 
consuming. A non-invasive, real-time point-of-care method could overcome these problems and facilitate regular screening. 
Infrared (IR) and Raman spectroscopy (RS) can non-invasively provide information regarding biochemical differences between 
normal and abnormal tissues. In this study, RS was employed to distinguish between different tissues-engineered models. 3D 
tissue engineered models of normal, dysplastic and head and neck squamous cell carcinoma (HNSCC) using normal oral 
keratinocytes, dysplastic (D19, D20 and DOK) and HNSCC cell lines (Cal27 , SCC4 and FaDu) were constructed and their biochemical 
content predicted by interpretation of  their spectral characteristics. Spectral features of normal tissue samples were mainly 
attributed to lipids, whereas, malignant tissue samples were observed to be protein dominant. Visible differences were found 
between the spectra of normal, dysplastic and cancerous models, specifically in the bands of amide I and III. The spectra of HNSCC 
models showed a broad and strong peak of amide I instead of the sharp and weak lipid peak in normal models at band centred at 
1667 cm-1. A shift at 2937 cm-1 was only observed in DOK, differentiating them from the other tissue types.  Principal Component 
Analysis (PCA) and Cluster Analysis (CA) distinguished noticeable differences between tissues. 
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1. INTRODUCTION  
Head and neck cancer (HNC) is the sixth most common 
malignancy worldwide. Histopathological analysis of surgical 
biopsies is the gold standard in diagnosing oral lesions. This 
procedure is highly respected but is associated with certain 
limitations such as delays in diagnosis due to several 
appointments, anxiety to patients because of surgical 
intervention, and only a small area of tissue can be analysed 
whereas tumour margin detection remains a challenge for 
surgeons. Early diagnosis would improve the quality of life 
for the patients therefore a technology capable of providing 
real time, non-invasive, and accurate diagnosis would 
revolutionise the field of oncology. Raman spectroscopy (RS) 
provides an optical spectrum obtained from the incident 
light and gives information regarding chemical composition, 
molecular conformations and biochemical changes in 
biological tissues non-invasively and real time [1]. 
The aim of this study is to assess the potential of Raman 
spectroscopy (RS) as a tool to identify the chemical pathway 
associated with the progression of oral cancer. 
2. MATERIALS AND METHODS 
Tissue engineered (T.E) models of normal mucosa (NOM) 
and HNC were generated by seeding 1x10^6 normal oral 
keratinocytes (NOK) or 2.5x10^5 HNC cells (Cal27, SCC4, 
FaDu, D19, D20 and DOK), respectively with 5x10^5 normal 
oral fibroblasts (NOF) onto de-epidermised dermis (DED) 
(Fig. 1) [2]. 
After 14 days culture models were fixed, wax embedded and 
sectioned for histological or RS analysis. 
The Raman spectra were recorded using a DXR Raman 
microscopic system (Thermo Scientific, Madison, WI, USA). 
The system was equipped with an Olympus BX51 optical 
microscope and a 532 nm diode-pumped solid state laser 
excitation source. Principal component analysis (PCA) was 
performed over the amide I (1550 cm-1 - 1750 cm-1) and 
amide III (1200 cm-1 – 1400 cm-1) regions of normal, 
dysplastic and cancerous data set. Pre-processing comprised 
of baseline correction and unit vector normalisation.  
 
3. RESULTS AND DISCUSSION 
Results showed increased intensities of tryptophan, 
phenylalanine, amide I and amide III are observed as the 
tissue changes from normal to dysplasia and cancer [3].  
CH region has shown a clear shift in abnormal tissues which 
might suggest the alterations in lipids as a result of lipid 
peroxidation associated with progression of disease.  
Broad peaks are observed at amide I and amide III regions in 
cancer model spectra due to protein dominancy as 
compared to sharp and weak lipid dominant peaks in normal 
model spectra (Fig. 3) [4]. 
PCA results have distinguished different tissue types on the 
basis of biochemical differences amongst them. Amide I and 
amide III regions have shown a minimum explained variance 
of 95%.  
 
4. FIGURES 
 
Figure 1. Diagram showing cell seeding onto the DED and inside the 
chamfered surgical stainless steel ring followed by lifting the model to an 
air liquid interface (ALI). 
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Figure 2. H&E stained images of tissue engineered oral mucosa; (a-c). 
Normal oral mucosa; (d-f). Dysplastic oral mucosa, DOK, D19 and D20 
respectively; (g-i). Cancerous oral mucosa Cal27, SCC4, and FaDu 
respectively, Yellow boxes indicate collection points for spectral data on 
unstained tissues. 
 
Figure 3(a). Average spectra of tissue engineered normal oral mucosa 
(NOM) (green) and dysplastic oral mucosa models D20 (yellow), D19 (blue) 
and DOK (red); (b). Average spectra of tissue engineered normal oral 
mucosa (NOM) (green) and cancerous oral mucosa models SCC4 (purple), 
FaDu (blue) and Cal27 (red).  
Figure 4. PCA analysis between normal dysplastic and cancer models in 
amide I and III region. 
 
5. CONCLUSIONS 
i. RS has the potential to differentiate between 
normal, dysplastic and cancer tissue models on the 
basis of their sub-cellular differences. 
ii. Compositional changes between the normal and 
cancerous models showed variations in both peak 
intensities and positions. 
iii. PCA results have shown clearer distinction between 
T.E normal, dysplastic and cancer models. 
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